1. Home
  2. CVRX

CVRX

CVRx Inc.

Logo CVRx Inc.

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Founded: 2000 Country:
United States
United States
Employees: 200 City: MINNEAPOLIS
Market Cap: 311.8M IPO Year: 2021
Target Price: $33.67 AVG Volume (30 days): 144.0K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.99 EPS Growth: N/A
52 Week Low/High: $8.93 - $33.14 Next Earning Date: 04-30-2024
Revenue: $39,295,000 Revenue Growth: 74.89%
Revenue Growth (this year): 43.3% Revenue Growth (next year): 37.70%

Share on Social Networks: